Sierra Summit Advisors’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.01M Sell
4,595
-25,120
-85% -$6.95M 0.11% 132
2026
Q1
$8.78M Buy
29,715
+24,418
+461% +$7.25M 1.28% 35
2025
Q4
$1.45M Sell
5,297
-175
-3% -$47.6K 0.22% 68
2025
Q3
$1.48M Sell
5,472
-100
-2% -$27.2K 0.23% 67
2025
Q2
$1.54M Sell
5,572
-50
-0.9% -$13.6K 0.27% 56
2025
Q1
$1.49M Hold
5,622
0.32% 55
2024
Q4
$1.31M Hold
5,622
0.26% 55
2024
Q3
$1.24M Hold
5,622
0.29% 51
2024
Q2
$1.11M Hold
5,622
0.27% 50
2024
Q1
$1.21M Hold
5,622
0.33% 47
2023
Q4
$1.18M Buy
+5,622
New +$1.2M 0.35% 48

Other funds holding CME

Sierra Summit Advisors's CME Position: Q2 2026 in Review

Sierra Summit Advisors reduced its CME Group (CME) stake by 85% in Q2 2026, selling an estimated $6.95M and leaving 4,595 shares worth $1.01M. The position accounts for 0.11% of the portfolio, ranked #132.

Sierra Summit Advisors first reported a position in CME in Q4 2023 and has held it in 11 quarters since. The position peaked at $8.78M in Q1 2026. 1,703 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Sierra Summit Advisors held 4,595 shares of CME Group worth $1.01M as of Q2 2026.
  • Sierra Summit Advisors sold 25,120 CME Group shares in Q2 2026, an estimated $6.95M.
  • CME Group made up 0.11% of Sierra Summit Advisors's portfolio in Q2 2026, its #132 holding.
  • Sierra Summit Advisors first reported a position in CME Group in Q4 2023 and has held it in 11 quarters since.
  • Sierra Summit Advisors's CME Group position peaked at $8.78M in Q1 2026.
  • 1,703 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Sierra Summit Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.